Literature DB >> 11161406

Risk of breast cancer among Norwegian women with visual impairment.

J Kliukiene1, T Tynes, A Andersen.   

Abstract

Experimental studies suggest that melatonin has a protective effect against breast cancer. Exposure to light suppresses melatonin secretion, but to a lesser degree in totally blind persons. Breast cancer was investigated in a cohort of 15 412 Norwegian visually impaired women. The risk among totally blind women was 0.64 (95% CI = 0.21-1.49, 5 cases only), and for those who became blind before age of 65, the SIR was 0.51 (95% CI = 0.11-1.49). Our findings give support to the 'melatonin hypothesis'.

Entities:  

Mesh:

Year:  2001        PMID: 11161406      PMCID: PMC2363754          DOI: 10.1054/bjoc.2000.1617

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

Review 1.  Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.

Authors:  B E Henderson; R Ross; L Bernstein
Journal:  Cancer Res       Date:  1988-01-15       Impact factor: 12.701

2.  Profound bilateral blindness and the incidence of breast cancer.

Authors:  R A Hahn
Journal:  Epidemiology       Date:  1991-05       Impact factor: 4.822

Review 3.  The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.

Authors:  T J Key; M C Pike
Journal:  Eur J Cancer Clin Oncol       Date:  1988-01

4.  A prospective study of reproductive factors and breast cancer. I. Parity.

Authors:  G Kvåle; I Heuch; G E Eide
Journal:  Am J Epidemiol       Date:  1987-11       Impact factor: 4.897

5.  Age at first birth and breast cancer risk.

Authors:  B MacMahon; P Cole; T M Lin; C R Lowe; A P Mirra; B Ravnihar; E J Salber; V G Valaoras; S Yuasa
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

6.  Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.

Authors:  L Tamarkin; M Cohen; D Roselle; C Reichert; M Lippman; B Chabner
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  Light suppresses melatonin secretion in humans.

Authors:  A J Lewy; T A Wehr; F K Goodwin; D A Newsome; S P Markey
Journal:  Science       Date:  1980-12-12       Impact factor: 47.728

8.  Effect of melatonin on B16 melanoma growth in athymic mice.

Authors:  T Narita; H Kudo
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

Review 9.  Melatonin: a coordinating signal for mammalian reproduction?

Authors:  L Tamarkin; C J Baird; O F Almeida
Journal:  Science       Date:  1985-02-15       Impact factor: 47.728

10.  Inverse association between breast cancer incidence and degree of visual impairment in Finland.

Authors:  P K Verkasalo; E Pukkala; R G Stevens; M Ojamo; S L Rudanko
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

View more
  22 in total

Review 1.  Light, timing of biological rhythms, and chronodisruption in man.

Authors:  Thomas C Erren; Russel J Reiter; Claus Piekarski
Journal:  Naturwissenschaften       Date:  2003-10-14

2.  Breast cancer risk among Finnish cabin attendants: a nested case-control study.

Authors:  K Kojo; E Pukkala; A Auvinen
Journal:  Occup Environ Med       Date:  2005-07       Impact factor: 4.402

Review 3.  Cancer and the Circadian Clock.

Authors:  Ayesha A Shafi; Karen E Knudsen
Journal:  Cancer Res       Date:  2019-07-12       Impact factor: 12.701

Review 4.  Shift work and cancer: the evidence and the challenge.

Authors:  Thomas C Erren; Puran Falaturi; Peter Morfeld; Peter Knauth; Russel J Reiter; Claus Piekarski
Journal:  Dtsch Arztebl Int       Date:  2010-09-24       Impact factor: 5.594

Review 5.  Protective role of melatonin in breast cancer: what we can learn from women with blindness.

Authors:  Chris Minella; Pierre Coliat; Shanti Amé; Karl Neuberger; Alexandre Stora; Carole Mathelin; Nathalie Reix
Journal:  Cancer Causes Control       Date:  2021-11-27       Impact factor: 2.506

Review 6.  Circulating melatonin and the risk of breast and endometrial cancer in women.

Authors:  Akila N Viswanathan; Eva S Schernhammer
Journal:  Cancer Lett       Date:  2008-12-12       Impact factor: 8.679

7.  Light-at-night, circadian disruption and breast cancer: assessment of existing evidence.

Authors:  Richard G Stevens
Journal:  Int J Epidemiol       Date:  2009-04-20       Impact factor: 7.196

8.  Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature.

Authors:  Michelle Basler; Alexander Jetter; Daniel Fink; Burkhardt Seifert; Gerd A Kullak-Ublick; Andreas Trojan
Journal:  Breast Care (Basel)       Date:  2014-07       Impact factor: 2.860

Review 9.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 10.  The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis.

Authors:  Lonnele J Ball; Oxana Palesh; Lance J Kriegsfeld
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.